Antitumor effects of immobilized protein A and staphylococcal products: linkage between toxicity and efficacy, and identification of potential tumoricidal reagents.
D000818:Animals; D003101:Collodion; D003165:Complement System Proteins / Q000276:immunology; D003561:Cytarabine / Q000627:therapeutic use; D004285:Dogs; D004357:Drug Synergism; D004768:Enterotoxins / Q000032:analysis; D006801:Humans; D007136:Immunoglobulins / Q000276:immunology; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000187:drug effects; D008934:Mitogens; D009369:Neoplasms / Q000188:drug therapy*; D013205:Staphylococcal Protein A / Q000009:adverse effects / Q000302:isolation & purification / Q000627:therapeutic use*
D004768:Enterotoxins; D007136:Immunoglobulins; D008934:Mitogens; D013205:Staphylococcal Protein A; D003561:Cytarabine; D003101:Collodion; D003165:Complement System Proteins